$500
Min. Investment
StartEngine
Platform
Convertible
Security
SEC Reg CF
Regulation
$40,026,291
Valuation Cap
Summary
RS BioTherapeutics, Inc. raised $196,189.48 on StartEngine through a SEC Reg CF crowdfunding campaign. Investments started at a minimum of US$500. The fundraise ended on July 29, 2024.
Total Capital Raised
$196,189
Total Raised
Jun 02, 2024
Start Date
Jul 29, 2024
Close Date
Closed
$196,189/$1,235,000
15.89%
90 investorsN/A$1,038,811 left
$500
Min. Investment
StartEngine
Platform
Convertible
Security
SEC Reg CF
Regulation
$40,026,291
Valuation Cap
Go To Pitch